$4.23B
$25.3 Million
0.01% of portfolio
2,453,555
Q3 2024
Reduced 62.23%
$1.51B
$1.43 Million
0.0% of portfolio
63,285
Q3 2024
Reduced 48.26%
$1.42B
$659,000
0.0% of portfolio
11,018
Q3 2024
Added 7.3%
$192M
$375,000
0.0% of portfolio
34,781
Q3 2024
Reduced 1.49%
$369M
$3.73 Million
0.0% of portfolio
504,563
Q3 2024
Reduced 39.37%
$295M
$500,000
0.0% of portfolio
246,540
Q3 2024
Reduced 1.27%
$1.33B
$919,000
0.0% of portfolio
63,664
Q3 2024
Added 3.56%
-
$0
0.0% of portfolio
-
Q3 2024
Added 3.62%
$7.73B
$6.76 Million
0.0% of portfolio
48,338
Q3 2024
Added 2.06%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 5.07%
$3.35B
$435,000
0.0% of portfolio
8,258
Q3 2024
New
$303M
$178,000
0.0% of portfolio
46,622
Q3 2024
New
$4.51B
$5.6 Million
0.0% of portfolio
95,822
Q3 2024
Added 0.6%
$4.07B
$6.67 Million
0.0% of portfolio
105,228
Q3 2024
Added 273.14%
$2.83B
$2.91 Million
0.0% of portfolio
188,965
Q3 2024
Reduced 0.12%
$2.22B
$1.29 Million
0.0% of portfolio
54,976
Q3 2024
Reduced 1.06%
$493M
$496,000
0.0% of portfolio
90,818
Q3 2024
Reduced 32.5%
$252M
$147,000
0.0% of portfolio
38,437
Q3 2024
Added 0.02%
-
$0
0.0% of portfolio
-
Q3 2024
Added 36.87%
Achieve Life Sciences Inc
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 36.04%
$840M
$570,000
0.0% of portfolio
28,098
Q3 2024
Reduced 79.2%
$335M
$228,000
0.0% of portfolio
5,223
Q3 2024
New
$77M
$8.8 Million
0.0% of portfolio
3,549,069
Q3 2024
Added 5.39%
$5.08B
$1.45 Million
0.0% of portfolio
22,831
Q3 2024
Added 2.46%
$2.43B
$831,000
0.0% of portfolio
40,935
Q3 2024
Added 5.29%
$1.28B
$736,000
0.0% of portfolio
65,601
Q3 2024
Added 20.23%
$2.02B
$3.48 Million
0.0% of portfolio
26,216
Q3 2024
Added 2.75%
$1.46B
$1.19 Million
0.0% of portfolio
99,760
Q3 2024
Added 21.87%
$1.66B
$1.35 Million
0.0% of portfolio
59,694
Q3 2024
Added 85.37%
$3.62B
$3.35 Million
0.0% of portfolio
167,644
Q3 2024
Added 19.35%
$6.11B
$356,000
0.0% of portfolio
49,298
Q3 2024
New
$4.3B
$915,000
0.0% of portfolio
12,138
Q3 2024
Added 11.65%
$9.61B
$6.55 Million
0.0% of portfolio
41,659
Q3 2024
Reduced 0.02%
$783M
$728,000
0.0% of portfolio
23,993
Q3 2024
Reduced 2.04%
$844M
$165,000
0.0% of portfolio
48,373
Q2 2024
Added 20.34%
Adverum Biotechnologies Inc
-
$0
0.0% of portfolio
-
Q3 2024
Added 0.0%
$15B
$636,000
0.0% of portfolio
6,162
Q3 2024
Added 1.5%
-
$0
0.0% of portfolio
-
Q3 2024
Added 0.52%
$475M
$152,000
0.0% of portfolio
11,888
Q2 2024
Added 12.41%
$4.09B
$966,000
0.0% of portfolio
4,821
Q3 2024
Added 299.42%
$15B
$280,000
0.0% of portfolio
6,878
Q3 2024
Added 2.0%
$6.8B
$665,000
0.0% of portfolio
6,793
Q3 2024
Reduced 79.98%
$3.26B
$10.7 Million
0.0% of portfolio
98,128
Q3 2024
Added 434.35%
$1.84B
$1.61 Million
0.0% of portfolio
36,317
Q3 2024
New
$5.14B
$6.11 Million
0.0% of portfolio
584,370
Q3 2024
Added 35.79%
$5.62B
$4.98 Million
0.0% of portfolio
66,153
Q3 2024
Added 8.25%
$1.64B
$431,000
0.0% of portfolio
26,645
Q3 2024
Added 31.19%
-
$0
0.0% of portfolio
-
Q3 2024
Added 13.95%
$14.4B
$2.38 Million
0.0% of portfolio
26,214
Q3 2024
Reduced 31.59%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 28.58%